BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28219644)

  • 1. The usefulness of 18F-fluorocholine PET/CT in the detection of recurrence of central nervous system primary neoplasms.
    Montes A; Fernández A; Camacho V; de Quintana C; Gallego O; Craven-Bartle J; López D; Molet J; Gómez-Ansón B; Carrió I
    Rev Esp Med Nucl Imagen Mol; 2017; 36(4):227-232. PubMed ID: 28219644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promising role of [18F] fluorocholine PET/CT vs [18F] fluorodeoxyglucose PET/CT in primary brain tumors-early experience.
    Lam WW; Ng DC; Wong WY; Ong SC; Yu SW; See SJ
    Clin Neurol Neurosurg; 2011 Feb; 113(2):156-61. PubMed ID: 21036467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy.
    Bader JB; Samnick S; Moringlane JR; Feiden W; Schaefer A; Kremp S; Kirsch CM
    Eur J Nucl Med; 1999 Feb; 26(2):144-51. PubMed ID: 9933348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Value of 68Ga PSMA-11 PET/CT Imaging of Brain Tumors-Preliminary Analysis.
    Sasikumar A; Joy A; Pillai MR; Nanabala R; Anees K M; Jayaprakash PG; Madhavan J; Nair S
    Clin Nucl Med; 2017 Jan; 42(1):e41-e48. PubMed ID: 27846000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ¹⁸F-Fluorocholine PET/CT as a complementary tool in the follow-up of low-grade glioma: diagnostic accuracy and clinical utility.
    Gómez-Río M; Testart Dardel N; Santiago Chinchilla A; Rodríguez-Fernández A; Olivares Granados G; Luque Caro R; Zurita Herrera M; Chamorro Santos CE; Lardelli-Claret P; Llamas-Elvira JM
    Eur J Nucl Med Mol Imaging; 2015 May; 42(6):886-95. PubMed ID: 25673054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of O-(2-[18F]fluoroethyl)- L-tyrosine PET for the diagnosis of recurrent glioma.
    Pöpperl G; Götz C; Rachinger W; Gildehaus FJ; Tonn JC; Tatsch K
    Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1464-70. PubMed ID: 15248032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot comparison of 18F-fluorodeoxyglucose and 18F-fluorocholine PET/CT to predict early recurrence of unifocal hepatocellular carcinoma after surgical resection.
    Fartoux L; Balogova S; Nataf V; Kerrou K; Huchet V; Rosmorduc O; Talbot JN
    Nucl Med Commun; 2012 Jul; 33(7):757-65. PubMed ID: 22504293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined 68Ga-NOTA-PRGD2 and 18F-FDG PET/CT Can Discriminate Uncommon Meningioma Mimicking High-Grade Glioma.
    Li D; Zhang J; Ji N; Zhao X; Zheng K; Qiao Z; Li F; Lang L; Iagaru A; Niu G; Zhu Z; Chen X
    Clin Nucl Med; 2018 Sep; 43(9):648-654. PubMed ID: 30052597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11C-Methionine Positron Emission Tomography/Computed Tomography Versus 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Evaluation of Residual or Recurrent World Health Organization Grades II and III Meningioma After Treatment.
    Tomura N; Saginoya T; Goto H
    J Comput Assist Tomogr; 2018; 42(4):517-521. PubMed ID: 29613985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of PET-CT with
    Puche-Sanz I; Triviño-Ibáñez E; Vázquez-Alonso F; Llamas-Elvira JM; Cózar-Olmo JM; Rodríguez-Fernández A
    Actas Urol Esp; 2017 Sep; 41(7):437-444. PubMed ID: 28389027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choline-PET/CT in the Differential Diagnosis Between Cystic Glioblastoma and Intraparenchymal Hemorrhage.
    Alongi P; Vetrano IG; Fiasconaro E; Alaimo V; Laudicella R; Bellavia M; Rubino F; Bagnato S; Galardi G
    Curr Radiopharm; 2019; 12(1):88-92. PubMed ID: 30117406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value.
    Van Laere K; Ceyssens S; Van Calenbergh F; de Groot T; Menten J; Flamen P; Bormans G; Mortelmans L
    Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):39-51. PubMed ID: 15309329
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Kanoun S; Walker P; Vrigneaud JM; Depardon E; Barbier V; Humbert O; Moulin M; Créhange G; Cormier L; Loffroy R; Brunotte F; Cochet A
    Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):986-994. PubMed ID: 28333020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers.
    DeGrado TR; Baldwin SW; Wang S; Orr MD; Liao RP; Friedman HS; Reiman R; Price DT; Coleman RE
    J Nucl Med; 2001 Dec; 42(12):1805-14. PubMed ID: 11752077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study.
    Cassou-Mounat T; Balogova S; Nataf V; Calzada M; Huchet V; Kerrou K; Devaux JY; Mohty M; Talbot JN; Garderet L
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1995-2004. PubMed ID: 27121691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorine-18 fluorocholine PET-CT localizes hyperparathyroidism in patients with inconclusive conventional imaging: a multicenter study from the Netherlands.
    Kluijfhout WP; Vorselaars WM; van den Berk SA; Vriens MR; Borel Rinkes IH; Valk GD; van Dalen T; de Klerk JM; de Keizer B
    Nucl Med Commun; 2016 Dec; 37(12):1246-1252. PubMed ID: 27612033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performances of [18F]fluorocholine positron emission tomography in brain tumors.
    Sollini M; Sghedoni R; Erba PA; Cavuto S; Froio A; De Berti G; Pisanello A; Fraternali A; Iori M; Iaccarino C; Iori M; Asti M; Filice A; Versari A
    Q J Nucl Med Mol Imaging; 2018 Jun; 62(2):209-219. PubMed ID: 26329494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Single center experience of (18F)-fluorocholine positron emission tomography: analysis of its impact on salvage local therapy in patients with prostate adenocarcinoma].
    Moussaid Y; Bonardel G; Jacob J; Métivier D; Gontier E; Bauduceau O; Durand X; Fayolle M; Houlgatte A; Foehrenbach H; Védrine L; Chargari C
    Cancer Radiother; 2013; 17(4):259-64. PubMed ID: 23702489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Dual Tracer 18F-FCH/18F-FDG PET Imaging of an Orthotopic Brain Tumor Xenograft Model.
    Fu Y; Ong LC; Ranganath SH; Zheng L; Kee I; Zhan W; Yu S; Chow PK; Wang CH
    PLoS One; 2016; 11(2):e0148123. PubMed ID: 26844770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
    Kosztyla R; Chan EK; Hsu F; Wilson D; Ma R; Cheung A; Zhang S; Moiseenko V; Benard F; Nichol A
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1100-6. PubMed ID: 24161427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.